期刊文献+

高血压病患者合并颈动脉粥样硬化与血清高敏C反应蛋白的相关性研究 被引量:3

Serum High-sensitivity C-reactive Protein Level is Associated with Carotid Atherosclerosis in Patients with Essential Hypertension
下载PDF
导出
摘要 目的研究合并颈动脉粥样硬化的高血压病患者血清高敏C反应蛋白(hsCRP)的变化,探讨两者之间的相关性。方法对来院就诊的188例原发性高血压患者进行颈动脉超声检查,测量颈总动脉内中膜厚度(IMT)、观察有无颈动脉斑块形成,从而判断有无颈动脉粥样硬化;同时进行血清hsCRP浓度的测定。分析血清hsCRP与颈动脉粥样硬化、颈总动脉内中膜厚度、颈动脉斑块形成之间的关系。结果①合并颈动脉粥样硬化的高血压病患者血清hsCRP显著高于无颈动脉病变者(P<0.01)。②颈总动脉内中膜增厚者血清hsCRP高于颈总动脉内中膜正常者(P<0.05);有颈动脉斑块的患者血清hsCRP明显高于无颈动脉斑块的患者(P<0.01)。结论高血压病合并颈动脉粥样硬化尤其是颈动脉斑块患者的血清hsCRP显著高于无颈动脉病变者,说明血清hsCRP与高血压病患者颈动脉粥样硬化的发生有一定相关性,炎症反应可能参与了高血压病颈动脉粥样硬化的形成。 Objective To study the relationship between serum high-sensitivity C-reactive protein (hsCRP) level and carotid atherosclerosis in patients with essential hypertension. Methods The serum concentrations of high-sensitivity C-reactive protein(hsCRP) were measured in one hundred and eighty-eight patients with essential hypertension. A Color Doppler Ultrasound system was used to investigate the intimal-medial thickness(IMT) of common carotid artery(CCA) and the plaque of carotid artery. Results ①The serum concentrations of hsCRP in the carotid atherosclerosis group were signicantly higher than that in the carotid artery normal group (P 〈 0.01). ②The serum concentrations of hsCRP in the carotid artery plaque group were signicantly higher than that in the non-carotid artery plaque group (P〈 0.01). These findings were also present in the group with IMT increasing (P 〈 0.05). Conclusions Serum high-sensitivity C-reactive protein level is associated with carotid atherosclerosis in patients with essential hypertension. Inflammatory response might play an important role in the pathogenesis of carotid atherosclerosis with essential hypertension.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2005年第6期1038-1040,共3页 Suzhou University Journal of Medical Science
关键词 高血压 颈动脉粥样硬化 高敏C反应蛋白 颈动脉斑块 hypertension carotid atherosclerosis c-reactive protein
  • 相关文献

参考文献11

  • 1Banach M, Markuszewski L, Zaslonka J, et al. The role of inflammation in the pathogenesis of atherosclerosis[J ].Przegl Epidemiol, 2004, 58: 663 - 6.70.
  • 2Jialal I, Daneman D. Inflammation and atherosclerosis:the value of the high-sensitivity C-reactive protein assay as a riskmarker[J]. Am J Clin Pathol, 2001, 6: 65-69.
  • 3Simons PC, Algra A, Bots ML, et al. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease)[J].Circulation, 1999, 100: 951-957.
  • 4Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention [ J ]. Circulation, 2003, 107 : 363 - 369.
  • 5Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis [ J ]? Eur Heart J, 2002, 23:831 - 834.
  • 6Torzewski M, Rist C, Mortensen RF, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyterecruitment in atherogenesis[J]. Arterioscler Thromb Vasc Biol, 2000, 20:2094-2099.
  • 7P ascrei V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells[ J ]. Circulation, 2000, 102 : 2165 - 2168.
  • 8Zwaka TP, Hombach V, Torzewski J. C-reactive protein mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis [ J ]. Circulation, 2001,103:1194 - 1197.
  • 9Hayaishi-Okano R, Yamasaki Y, Katakami N, et al.Elevated C-reactive protein associates with early-stage carotid atherosclerosis in yong subjects with 1 diabetes[J]. Diabetes Care, 2002, 25:1432-1438.
  • 10Sasaki R, Yamano S, Yamamoto T, et al. Vascular remodeling of the carotid artery in patients with untreated essential hypertension increases with age [ J ].Hypertens Res, 2002, 25 : 373 - 379.

同被引文献14

  • 1Kuge Y, Takai N, Ishino S, et al. Distribution profiles of membrane Type-1 matrix metalloproteinase (MT1-MMP) , matrix metalioproteinase-2 (MMP-2) and cyclooxygenase-2 (COX-2) in rabbit atherosclerosis: comparison with plaque instability analysis[J]. Biol Pharm Bull, 2007,30 (9) :1634 - 1640.
  • 2Zureik M, Beaudeux JL, Courbon D,et al. Serum tissue inhibitors of metalloproteinases 1 ( TIMP-1 ) and carotid atherosclerosis and aortic arterial stiffness [J]. J Hypertens, 2005,23 (12) :2263 - 2268.
  • 3Jose RR, Ramachandran SV, Alexa SB, et al. Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the framingham off- spring study[ J ]. J Stroke Cerebrovasc Dis,2008,17 ( 6 ) : 412 - 417.
  • 4Kumada M, Kihara S, Ouchi N, et al. Adiponectin speci- fically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages [J]. Circulation,2004,109 ( 17 ) : 2046 - 2049.
  • 5Galia ZS, Mmnwki M,Sakhova GK,et al. Enhanced exprsssion of vascular matrixmetallopo-teinases in vitro by cytokines and in regions of human atherosclerotic lesions [ J ]. Ann NY Acad Sci, 1995,748 ( 3 ) :501 - 507.
  • 6Galis ZS, Sukhova GK, Kranzhofer R, et al. Mactrophag foam cells fiom experimental atheroma constitutively produce matridegrading proteinase [ J ]. Proc Natl Acad Sci USA, 1995,92 (2) : 402 - 406.
  • 7Basu P, Sen U, Tyagi T, et al. Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function [J]. Vascular Health and Risk Management, 2010,6(3):215 - 228.
  • 8Nanni S, Melandri G, Hanemaaijer R, et al. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms [ J ]. Transl Res,2007,149 ( 3 ) : 137 - 144.
  • 9Poole C,Conway P,Currie J,et al.An evaluation of the association between system ic inflammation-as measured by C-reactive protein and hospital resource use.Curr Med Res()pin,2007,23:2785-2792.
  • 10史志保,胡小伟,董万利.心脑血管疾病高危患者高敏C反应蛋白的变化[J].苏州大学学报(医学版),2008,28(6):1024-1025. 被引量:4

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部